Declining Hospitalization Rate of Esophageal Variceal Bleeding in the United States

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 6, 2008, Pages 689-695

  Jamal, M Mazen ^a,b   Samarasena, Jason B ^a,b   Hashemzadeh, Mehrtash ^a   Vega, Kenneth J ^c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DATA ANALYSIS; DATA BASE; ESOPHAGUS VARICES BLEEDING; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PORTAL HYPERTENSION; TREATMENT OUTCOME; UNITED STATES;

ESOPHAGEAL AND GASTRIC VARICES; HEMORRHAGE; HOSPITALIZATION; HUMANS; UNITED STATES;

EID: 44749087827     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.02.049     Document Type: Article

References (36)

1. D'amico G., Pagliaro L., and Bosch J. The treatment of portal hypertension: a meta analytic review. Hepatology 22 (1995) 332-354
2. Burroughs A.K. The natural history of varices. J Hepatol 17 Suppl 2 (1993) S10-S13
3. Stokkeland K., Brandt L., Ekbom A., et al. Improved prognosis of patients hospitalized with esophageal varices in Sweden 1969-2002. Hepatology 43 (2006) 500-505
4. Carbonell N., Pauwels A., Serfaty L., et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (2004) 652-659
5. Clark J.M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40 (2006) S5-S10
6. Williams R. Global challenges in liver disease. Hepatology 44 (2006) 521-526
7. Rustgi V. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 42 (2007) 513-521
8. Healthcare Cost and Utilization Project. Nationwide inpatient sample (NIS) (2002), Agency for Healthcare Research and Quality, Rockville, MD
9. State Ambulatory Surgery Database. Introduction to the state ambulatory database (2003), Agency for Healthcare Research and Quality, Rockville, MD
10. Public Health Service, Health Care Financing Administration. International classification of diseases, 9th revision, clinical modification (ICD-9-CM) (1991), U.S. Department of Health and Human Services, Washington, DC
11. SPSS 13.0, copyright 2005. Chicago, IL: SPSS Inc.
12. Zein N.N. The epidemiology and natural history of hepatitis C virus infection. Cleve Clin J Med 70 Suppl 4 (2003) S2-S6
13. Nguyen G.C., Segev D.L., and Thuluvath P.J. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol 5 (2007) 1092-1099
14. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A., et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326 (1992) 1527-1532
15. Sarin S.K., Lamba G.S., Kumar M., et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 340 (1999) 988
16. Sanyal A.J., Freedman A.M., Luketic V.A., et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 126 (1997) 849
17. Bosch J., Abraldes J.G., and Groszmann R. Current management of portal hypertension. J Hepatol 38 (2003) 54-68
18. Jalan R., John T.G., Redhead D.N., et al. Comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 90 (1995) 1932-1937
19. Pascal J.P., and Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 317 (1987) 856-861
20. Merkel C., Marin R., Angeli P., et al., Gruppo Triveneto per l'Ipertensione Portale. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 127 (2004) 476-484
21. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46 (2007) 922
22. Chalasani N., Kahi C., Francois F., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-659
23. Mandayam S., Jamal M.M., and Morgan T.R. Epidemiology of alcoholic liver disease. Semin Liver Dis 24 (2004) 217-232
24. Lakins N.E., Williams G.D., Yi H., et al. NIAAA: Alcohol Epidemiologic Data System Surveillance Report #73: apparent per capita alcohol consumption: national, state, and regional trends, 1970-2003 (2005), National Institute on Alcohol Abuse and Alcoholism, Division of Epidemiology and Prevention Research, Bethesda, MD
25. Mann R.E., Smart R.G., and Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 27 (2003) 209-219
26. Armstrong G.L., Alter M.J., McQuillan G.M., et al. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 31 (2000) 777-782
27. Davis G.L., Albright J.E., Cook S.F., et al. Projecting future complications of chronic hepatitis C in the United States. Liver Transplantation 9 (2003) 331-338
28. Harrison S.A., Torgerson S., and Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98 (2003) 2042-2047
29. Gunnarsdottir S.A., Olsson R., and Björnsson E.S. Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994-1999. Scand J Gastroenterol 40 (2005) 1462-1468
30. Grace N. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 92 (1997) 1081-1091
31. Grace N.D., Groszman R.J., Garcia-Tsao G., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 28 (1998) 868-880
32. Zaman A., Hapke R., Flora K., et al. Changing compliance to the American College of Gastroenterology guidelines for the management of variceal hemorrhage: a regional survey. Am J Gastroenterol 99 (2004) 645-649
33. Rawls R.A., and Vega K.J. Viral hepatitis in minority America. J Clin Gastroenterol 39 (2005) 144-151
34. Yen T., Keeffe E.B., and Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 36 (2003) 47-53
35. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341 (1999) 556-562
36. Browning J.D., Kumar K.S., Saboorian H., et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroentrol 99 (2004) 292-298